~~<i id='B60DE6BB2F'><strike id='B60DE6BB2F'><tt id='B60DE6BB2F'><pre id='B60DE6BB2F'></pre></tt></strike></i>~~

Home» comprehensive» leisure time

leisure time

author：focus 2025-09-30 12:50:01 Page View：223

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Judge rejects Trump's counterclaim against E. Jean Carroll
Next article： As demand for Covid shots wanes, Moderna seeks its next success

explore

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

AdobeSometimes,anappleadayreallyisjustwhatthedoctorordered.Andforthepastseveralyears,organizationsli

FTX founder Sam Bankman

1:27FTXfounderSamBankman-FriedisledawayhandcuffedbyofficersoftheRoyalBahamasPoliceForceinNassau,Baha

DIEP, the 'gold standard' of breast reconstruction, is under threat

AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

'Of course' Trump lost the 2020 election, DeSantis says after years of hedging

5:06RepublicanpresidentialcandidateFloridaGov.RonDeSantisspeaksduringafundraisingeventforU.S.Rep.Ash